期刊文献+

胰岛素不同部位皮下注射对2型糖尿病患者血糖漂移的影响 被引量:1

Effects of the different hypodermic injection site of insulin on blood glucose fluctuations in type 2 diabetic patients
原文传递
导出
摘要 目的观察胰岛素皮下注射部位不同的2型糖尿病患者血糖水平的漂移变化。方法30例2型糖尿病患者随机分为三组:腹部皮下注射组(A组,10例)、臂部三角肌皮下注射组(B组,10例)和股外侧皮下注射组(C组,10例)。胰岛素强化治疗半个月后,动态血糖监测系统进行连续(71±10)h血糖监测,动态血糖监测数值(847±80)个。结果三组患者平均血糖水平差异无统计学意义,但腹部皮下注射组日内血糖最高值、日内血糖漂移最大幅度均显著低于其他两组患者(P〈0.05);腹部皮下注射组日内血糖最低值和血糖漂移于3.6~10.0mmol/L所占的日内时间百分比高于其他两组患者(P〈0.05)。结论胰岛素皮下注射部位的选择对2型糖尿病患者血糖漂移水平有明显影响,以腹部皮下注射组血糖漂移幅度最小。 Objective To observe the fluctuations of blood glucose in type 2 diabetic patients treated by insulin hypodermic injection in different sites. Methods 30 patients with type 2 diabetes were randomly divided into three groups:abdominal, edltoid region and lateral femoral subcutaneous injection group. After half a year of insulin therapy, dynamic glucose monitoring for consecutive (71 ± 10) hours was conducted, and (847 ± 80 ) results of glucose level were obtained. Results The average glucose had no difference in three group, but diurnal maximum and maximum fluctuation amplitude in patients of abdominal subcutaneous injection group were significantly lower than the other groups(P 〈 0.05 ). The time percentage of glycemic fluctuations within 3.6 - 10.0mmol/L and diurnal /ninimum was higher compared to other groups( P 〈 0.05). Conclusion The site choice of insulin subcutaneous injection can influence the fluctuations of blood glucose in type 2 diabetes mellitus and abdominal subcutaneous tissue was the most ideal of the three subcutaneous injection sites.
出处 《中国基层医药》 CAS 2008年第8期1239-1240,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 糖尿病 2型 胰岛素 血糖 Diabetic mellitus, type 2 Insulin Blood glucose
  • 相关文献

参考文献7

  • 1Brownlee M, Hirsch IB. Glycemic variability : a hemoglobin Alc-independent risk factor for diabetic complications. JAMA,2006,295 (14) : 1707-1708.
  • 2傅袒植,叶任高.内科学.5版.北京:人民卫生出版社,2001:810-812
  • 3American Association of Diabetes Educators. Intensive diabetes management:implications of the DCCT and UKPDS. Diabetes Educ, 2002,28 ( 5 ) : 735-740.
  • 4Genuth S. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract, 2006,12 ( S1 ) : 34- 41.
  • 5Vaag AA. Giycemic control and prevention of microvascular and macrovascular disease in the Steno 2 study. Endocr Pract, 2006, 12(S1) :89-92.
  • 6Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care, 2001,24 (12) : 2030-2034.
  • 7Marfella R, Nappo F, De Angelis L, et al. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care, 2000,23 (5) :658-663.

同被引文献13

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部